ESR1 and breast cancer: Breast cancer with negative expression of ER, PR and HER2 is called triple-negative breast cancer (TNBC), which is characterized by poor differentiation, high invasiveness, propensity for local and distant metastasis, poor prognosis, and high recurrence rate.1